Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00565045 · ClinicalTrials.gov registry record · Phase 1
Treatments for Recovery of Hand Function in Acute Stroke Survivors
A Phase 1 study, sponsored by MetroHealth Medical Center.
- Completed
- Registry status
- Phase 1
- Development phase
- 21
- Enrollment target
NCT00565045: Completed Phase 1 study, sponsored by MetroHealth Medical Center.
NCT00565045 is a Phase 1 study that has completed, run by MetroHealth Medical Center. The registered enrollment target is 21 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (65% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00565045, a Phase 1 study, has completed, sponsored by MetroHealth Medical Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 21 participants
- Enrollment target
Study Summary
Impaired hand function is one of the most frequently persisting consequences of stroke. The purpose of this study is to investigate whether two different types of treatment improve recovery of hand function after stroke.
Primary Outcome
A custom-built electrogoniometer recorded the angles of the metacarpophalangeal (MP) and proximal interphalangeal (PIP) joints of the index finger simultaneously. Participants were seated with the forearm and wrist supported and stabilized in a neutral posture. From this resting postion, they were instructed to extend their fingers as fully as possible in response to a 4-sec audio cue. The MP and PIP angles were added together, providing a composite measure of degree of finger extension, where 0
Interventions
- DEVICE Neuromuscular electrical stimulator
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2007-07 |
| Est. Completion | 2010-04 |
| Phase | Phase 1 |
What the finished NCT00565045 record still lists
NCT00565045 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 21 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (65% lower).
The record links to 0 conditions, and to 1 intervention - of which Neuromuscular electrical stimulator is the first listed.
NCT00565045 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00565045 about?
NCT00565045 is a clinical study titled "Treatments for Recovery of Hand Function in Acute Stroke Survivors". Impaired hand function is one of the most frequently persisting consequences of stroke. The purpose of this study is to investigate whether two different types of treatment improve recovery of hand function after stroke.
What is the current status of trial NCT00565045?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 21 participants. The study started on 2007-07. Estimated completion is 2010-04.
What interventions are being tested in trial NCT00565045?
The interventions under investigation include: Neuromuscular electrical stimulator (DEVICE).
Who is sponsoring clinical trial NCT00565045?
This trial is sponsored by MetroHealth Medical Center, which has 76 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00565045's enrollment target sits among peer trials
21 1615th of 2000 higher than 372 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02447874 · 21 participants · Phase 1
Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease
- NCT03826992 · 21 participants · Phase 1
Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia
- NCT04107077 · 21 participants · Phase 2
Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer
- NCT04158635 · 21 participants · Phase 1
Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia